Diagnostic efficacy of ascites cell block for ovarian clear cell carcinoma. 2021

Hideki Iwahashi, and Morikazu Miyamoto, and Shinya Minabe, and Taira Hada, and Takahiro Sakamoto, and Hiroki Ishibashi, and Soichiro Kakimoto, and Hiroko Matsuura, and Rie Suzuki, and Susumu Matsukuma, and Hitoshi Tsuda, and Masashi Takano
Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Tokorozawa, Japan.

BACKGROUND Ascites cytology is important for determining the stage and treatment methods for ovarian clear cell carcinoma (CCC) as defined by the 2014 International Federation of Obstetrics and Gynecology classification. METHODS Patients with CCC who underwent surgery at our hospital between January 2012 and December 2019 and who received cytodiagnosis of their ascites using Papanicolaou (Pap) and May-Grünwald-Giemsa (MGG) staining, and cell block methods were identified. The cell block technique was performed using hematoxylin-eosin (H&E) staining and immunohistochemical staining for hepatocyte nuclear factor-1β (HNF-1β), estrogen receptor (ER), progesterone receptor (PR), and Wilms tumor-1 (WT-1). Cancer cells of CCC were defined as tumor cells that were positive for HNF-1β and negative for ER, PR, and WT-1. The diagnostic accuracy of ascites cytology using Pap and MGG staining and cell block methods was examined. RESULTS Based on cytological data, our study included 17 patients: seven (41.1%) with malignant (MAL) ascites, eight (47.1%) with negative for malignancy (NFM), and two (11.8%) with atypia of undetermined significance (AUS) because of a few atypical cells based on Pap and MGG staining. Malignant cells diagnosed by cell blocks were detected in 7/7 patients with MAL ascites based on PAP and MGG staining, 2/8 (25.0%) patients with NFM, and 1/2 (50%) patients with AUS. CONCLUSIONS These findings show that the cell block method combined with the immunohistochemical investigation may be useful for increasing the diagnostic accuracy of malignant cells in CCC.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008751 Methylene Blue A compound consisting of dark green crystals or crystalline powder, having a bronze-like luster. Solutions in water or alcohol have a deep blue color. Methylene blue is used as a bacteriologic stain and as an indicator. It inhibits GUANYLATE CYCLASE, and has been used to treat cyanide poisoning and to lower levels of METHEMOGLOBIN. Methylthionine Chloride,Swiss Blue,Basic Blue 9,Chromosmon,Methylene Blue N,Methylthioninium Chloride,Urolene Blue,Blue 9, Basic,Blue N, Methylene,Blue, Methylene,Blue, Swiss,Blue, Urolene
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010533 Peritoneal Lavage Washing out of the peritoneal cavity. The procedure is a diagnostic as well as a therapeutic technique following abdominal trauma or inflammation. Irrigation, Peritoneal,Lavage, Peritoneal,Peritoneal Irrigation
D003581 Cytodiagnosis Diagnosis of the type and, when feasible, the cause of a pathologic process by means of microscopic study of cells in an exudate or other form of body fluid. (Stedman, 26th ed) Cytodiagnoses
D004801 Eosine Yellowish-(YS) A versatile red dye used in cosmetics, pharmaceuticals, textiles, etc., and as tissue stain, vital stain, and counterstain with HEMATOXYLIN. It is also used in special culture media. Eosin,Eosine Yellowish,Tetrabromofluorescein,Acid Red 87,C.I. Acid Red 87,Eosin (yellowish) (free acid),Eosin Y,Eosine,Eosine Yellowish-(YS), Dipotassium Salt,Eosine Yellowish-(YS), Potassium, Sodium Salt
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Hideki Iwahashi, and Morikazu Miyamoto, and Shinya Minabe, and Taira Hada, and Takahiro Sakamoto, and Hiroki Ishibashi, and Soichiro Kakimoto, and Hiroko Matsuura, and Rie Suzuki, and Susumu Matsukuma, and Hitoshi Tsuda, and Masashi Takano
September 2015, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Hideki Iwahashi, and Morikazu Miyamoto, and Shinya Minabe, and Taira Hada, and Takahiro Sakamoto, and Hiroki Ishibashi, and Soichiro Kakimoto, and Hiroko Matsuura, and Rie Suzuki, and Susumu Matsukuma, and Hitoshi Tsuda, and Masashi Takano
January 2021, Journal of Cancer,
Hideki Iwahashi, and Morikazu Miyamoto, and Shinya Minabe, and Taira Hada, and Takahiro Sakamoto, and Hiroki Ishibashi, and Soichiro Kakimoto, and Hiroko Matsuura, and Rie Suzuki, and Susumu Matsukuma, and Hitoshi Tsuda, and Masashi Takano
January 1979, Gynakologische Rundschau,
Hideki Iwahashi, and Morikazu Miyamoto, and Shinya Minabe, and Taira Hada, and Takahiro Sakamoto, and Hiroki Ishibashi, and Soichiro Kakimoto, and Hiroko Matsuura, and Rie Suzuki, and Susumu Matsukuma, and Hitoshi Tsuda, and Masashi Takano
March 2017, Molecular cancer research : MCR,
Hideki Iwahashi, and Morikazu Miyamoto, and Shinya Minabe, and Taira Hada, and Takahiro Sakamoto, and Hiroki Ishibashi, and Soichiro Kakimoto, and Hiroko Matsuura, and Rie Suzuki, and Susumu Matsukuma, and Hitoshi Tsuda, and Masashi Takano
March 2023, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
Hideki Iwahashi, and Morikazu Miyamoto, and Shinya Minabe, and Taira Hada, and Takahiro Sakamoto, and Hiroki Ishibashi, and Soichiro Kakimoto, and Hiroko Matsuura, and Rie Suzuki, and Susumu Matsukuma, and Hitoshi Tsuda, and Masashi Takano
August 2023, Anticancer research,
Hideki Iwahashi, and Morikazu Miyamoto, and Shinya Minabe, and Taira Hada, and Takahiro Sakamoto, and Hiroki Ishibashi, and Soichiro Kakimoto, and Hiroko Matsuura, and Rie Suzuki, and Susumu Matsukuma, and Hitoshi Tsuda, and Masashi Takano
December 2010, Cancer science,
Hideki Iwahashi, and Morikazu Miyamoto, and Shinya Minabe, and Taira Hada, and Takahiro Sakamoto, and Hiroki Ishibashi, and Soichiro Kakimoto, and Hiroko Matsuura, and Rie Suzuki, and Susumu Matsukuma, and Hitoshi Tsuda, and Masashi Takano
February 2015, Gan to kagaku ryoho. Cancer & chemotherapy,
Hideki Iwahashi, and Morikazu Miyamoto, and Shinya Minabe, and Taira Hada, and Takahiro Sakamoto, and Hiroki Ishibashi, and Soichiro Kakimoto, and Hiroko Matsuura, and Rie Suzuki, and Susumu Matsukuma, and Hitoshi Tsuda, and Masashi Takano
December 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Hideki Iwahashi, and Morikazu Miyamoto, and Shinya Minabe, and Taira Hada, and Takahiro Sakamoto, and Hiroki Ishibashi, and Soichiro Kakimoto, and Hiroko Matsuura, and Rie Suzuki, and Susumu Matsukuma, and Hitoshi Tsuda, and Masashi Takano
December 2007, Histopathology,
Copied contents to your clipboard!